November 3, 2017 Microscopy PR/Corporate

ZEISS Strengthens Sales and Service in Russia, Ukraine, CIS Countries and Georgia through Acquisition of Majority Stake in Optec Group

OBERKOCHEN/Germany, MOSCOW/Russia, 2017-11-03. ZEISS will strengthen its activities in Russia, the Ukraine, the Commonwealth of Independent States (CIS) and Georgia by acquiring a majority stake in the Optec Group, – the long-standing sales and service partner responsible for this territory. With this step, ZEISS is continuing and expanding its almost 115-year presence in the region.... Read more

November 3, 2017 PR/Corporate

Honeywell Announces Determination of Pricing Terms of Private Exchange Offers for Four Series of Notes

MORRIS PLAINS, N.J., Nov. 3, 2017 /PRNewswire/ — Honeywell (NYSE: HON) today announced the determination of the pricing terms of its previously announced four separate private offers to exchange any and all of its outstanding notes listed below (the “Existing Notes”) for a combination of newly issued debt securities of Honeywell and cash (the “Exchange Offers”). The... Read more

November 3, 2017 PR/Corporate

AMETEK To Present At Baird's 2017 Global Industrial Conference

BERWYN, Pa., Nov. 3, 2017 /PRNewswire/ — AMETEK, Inc. (NYSE: AME) will present at Baird’s 2017 Global Industrial Conference on Tuesday, November 7, 2017. David Zapico, Chairman and Chief Executive Officer, will represent the Company. AMETEK’s presentation is scheduled for 3:00 PM ET. The presentation will be simultaneously webcast over the Internet. The live audio webcast... Read more

November 2, 2017 Life Science Tools PR/Corporate

Pacific Biosciences Appoints Kathy Ordoñez as Chief Commercial Officer

MENLO PARK, Calif., Nov. 02, 2017 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ:PACB) announced today that Kathy Ordoñez has been named Chief Commercial Officer and Executive Vice President. Ms. Ordoñez brings more than thirty years of experience in the life sciences and diagnostics industries, with senior roles at Hoffmann-La Roche, Celera, Quest Diagnostics and... Read more

November 1, 2017 Acad, Gov/Utilities PR/Corporate Product Launch

Roche to present new data across a range of blood diseases at the American Society of Hematology (ASH) 2017 Annual Meeting

Basel, 01 November 2017 Roche to present new data across a range of blood diseases at the American Society of Hematology (ASH) 2017 Annual Meeting Further results from emicizumab phase III studies in people with haemophilia A with inhibitors will be featured New data for polatuzumab vedotin in a difficult-to-treat blood cancer, which led to... Read more

November 1, 2017 Acad, Gov/Utilities PR/Corporate Product Launch

Roche to present new data across a range of blood diseases at the American Society of Hematology (ASH) 2017 Annual Meeting

Basel, 01 November 2017 Roche to present new data across a range of blood diseases at the American Society of Hematology (ASH) 2017 Annual Meeting Further results from emicizumab phase III studies in people with haemophilia A with inhibitors will be featured New data for polatuzumab vedotin in a difficult-to-treat blood cancer, which led to... Read more

November 1, 2017 PR/Corporate

Spectris Appoints General Counsel and Company Secretary

1 November 2017 – Spectris plc (‘Spectris’) (LSE: SXS), the productivity-enhancing instrumentation and controls company, announces the appointment of Mark Serföző as General Counsel (since 9 October 2017) and from today as Company Secretary. Mark is a member of the Spectris Executive Committee. Mark replaces Roger Stephens who is retiring from Spectris at the year... Read more